Meghan Scanlon - Jul 1, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP,Pres,Urology Pelvic Health
Signature: /s/ Mai-Khoi Nguyen-Thanh, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: Jul 1, 2021
Transactions value $: -$10,883
Form type: 4
Date filed: 7/6/2021, 04:12 PM
Previous filing: Jun 28, 2021
Next filing: Jul 27, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+855	+4.8%	$0.00	18.7K	Jul 1, 2021	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$10.9K	-251	-1.34%	$43.36	18.4K	Jul 1, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-855	-100%	$0.00^*	0	Jul 1, 2021	Common Stock	855		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on July 1, 2017, the first anniversary of the date of grant.